Azithromycin Pediatric Dosing
For most pediatric infections, administer azithromycin 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg (maximum 250 mg) daily for days 2-5. 1
Standard Dosing Regimens by Indication
Community-Acquired Pneumonia and Atypical Pneumonia
- Use the 5-day regimen: 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg (max 250 mg) daily for days 2-5 for pneumonia caused by Mycoplasma pneumoniae, Chlamydia pneumoniae, or Chlamydia trachomatis 1
- This regimen is recommended by both the American Academy of Pediatrics and the Infectious Diseases Society of America for children ≥6 months 1
- Important caveat: Azithromycin is NOT first-line for typical bacterial pneumonia caused by S. pneumoniae or H. influenzae—amoxicillin remains the preferred agent for these pathogens 1
Pertussis Treatment and Prophylaxis
- Infants <6 months: 10 mg/kg once daily for 5 days 1
- Children ≥6 months: 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg (max 250 mg) daily for days 2-5 1
- Azithromycin is preferred over erythromycin in young infants due to better safety profile and lower risk of gastrointestinal side effects 1
Streptococcal Pharyngitis (Strep Throat)
- Critical point: Azithromycin is SECOND-LINE therapy only; penicillin or amoxicillin remain first-line 1
- If azithromycin must be used: 12 mg/kg once daily for 5 days (maximum 500 mg/day) 1
- The higher dose (12 mg/kg vs. standard 10 mg/kg) is necessary because standard dosing results in high recurrence rates 1, 2
- Studies show the 10 mg/kg regimen has a 40.5% bacteriologic relapse rate at 1 month, compared to only 13-15% with higher dosing or penicillin 2
Chlamydial Infections in Adolescents
- Uncomplicated urethritis or cervicitis: Single 1 gram oral dose 1
MAC Prophylaxis in HIV-Infected Children
- 20 mg/kg body weight (maximum 1,200 mg) by mouth weekly 1
Weight-Based Dosing Alternative
For children who cannot be dosed by mg/kg calculation, use these weight-based doses for once-daily administration 1:
- 15-25 kg: 200 mg once daily
- 26-35 kg: 300 mg once daily
- 36-45 kg: 400 mg once daily
- ≥46 kg: 500 mg once daily
Intravenous Dosing
When parenteral therapy is required for atypical pneumonia, give 10 mg/kg IV once daily (max 500 mg) on days 1-2, then transition to oral therapy as soon as clinically feasible 1
Common pitfall to avoid: Do not continue IV therapy beyond 2 days when oral therapy is tolerated 1. Remember that IV azithromycin is specifically for atypical pathogens—typical bacterial pneumonia requires beta-lactam antibiotics as first-line 1
Special Populations
Infants <1 Month
- Azithromycin is the preferred macrolide for pertussis treatment: 10 mg/kg once daily for 5 days 1
- Monitor for infantile hypertrophic pyloric stenosis (IHPS), though azithromycin has not been strongly associated with this condition 1
- The benefits of treating severe pertussis outweigh potential risks in this age group 1
Renal and Hepatic Impairment
- No specific dose adjustments are provided in the guideline evidence for pediatric patients with renal or hepatic impairment
- Use clinical judgment and monitor closely, as azithromycin undergoes hepatic metabolism and has minimal renal excretion (approximately 9% urinary excretion) 3
Alternative Macrolides for Allergic Patients
If the patient is allergic to azithromycin 1, 4:
- Clarithromycin: 15 mg/kg/day divided into 2 doses (better tolerated, preferred)
- Erythromycin: 40 mg/kg/day divided into 4 doses
- Doxycycline: Only for children >7 years old (avoid in younger children due to dental staining)
Important Drug Interactions and Administration Considerations
- Do not administer with aluminum- or magnesium-containing antacids, as they significantly reduce absorption 1
- Space antacids at least 2 hours before or after azithromycin
- Monitor for QT interval prolongation when used with other QT-prolonging medications 1
- Monitor when used with drugs metabolized by cytochrome P450 enzyme system 1
Safety Profile
- Azithromycin has fewer gastrointestinal side effects compared to erythromycin 1
- Common adverse effects include abdominal discomfort, diarrhea, nausea, vomiting, headache, and dizziness 1
- Treatment-related adverse events occur in approximately 9% of patients and are typically mild to moderate 5
- Higher doses (20 mg/kg/day) are associated with more adverse effects (23%) compared to standard doses (18%), but still generally well-tolerated 2
- FDA Pregnancy Category B 1
Maximum Dosing Rule
Never exceed adult doses regardless of weight: maximum 500 mg on day 1 and 250 mg daily for the standard 5-day respiratory regimen 1